Semaglutide is a glucagon-like peptide-1 receptor agonist (GLP-1 RA) approved by the FDA for the treatment of type 2 diabetes mellitus and chronic weight management
As a result, you dont feel as hungry as often and remain satisfied after a meal or snack
doi:10.1016/j.juro.2012.03.131
Why Semaglutide Causes Nausea and How It Works Semaglutide activates GLP-1 receptors in the brainstem and gastrointestinal tract, signaling fullness and slowing stomach emptyingthe mechanism that drives weight loss and blood sugar control
Este contenido es de carcter general y no sustituye la valoracin mdica individualizada.
If you are taking tirzepatide along with other diabetes medications, please be alert for symptoms of low blood sugar, such as shakiness, sweating, confusion, or a rapid heartbeat